Ordering Information
| Catalog No. |
Product Name |
Target Species |
Size |
Availability |
| ELI-33908h |
Human CHMP4C ELISA KIT |
Human (Homo sapiens) |
96 Tests |
In Stock |
Technical Specifications
| Catalog Number |
ELI-33908h |
Target Biomarker |
Charged Multivesicular Body Protein 4C (CHMP4C) |
| Assay Methodology |
Sandwich ELISA |
Subcellular Location |
Cytoplasm / Midbody / Endosomal Membrane |
| Detection Range |
78 – 5000 pg/mL |
Sensitivity |
32 pg/mL |
| Validated Samples |
Serum, Plasma, Tissue Homogenates, Cell Culture Supernatant, Other Biological Fluids |
Gene Name |
CHMP4C |
| Chromosomal Location |
8q22.2 |
UniProt ID |
Q9H444 |
| Protein Properties |
~23 kDa molecular mass, 222 amino acids, member of ESCRT-III family, contains SNF7 domain, forms helical filaments, cytosolic protein recruited to membranes upon activation |
| Alternative Names |
Shax1 (SH3PX1-associated protein), Chromatin Modifying Protein 4C, hVps32C, VPS32C, CHMP4C-like protein |
Validation Data & Performance
Precision
| Intra-assay Precision |
| Sample | n | Mean | CV% |
| Sample 1 | 20 | See Manual | <10% |
| Sample 2 | 20 | See Manual | <10% |
| Sample 3 | 20 | See Manual | <10% |
| Inter-assay Precision |
| Sample | n | Mean | CV% |
| Sample 1 | Multiple assays | See Manual | <12% |
| Sample 2 | Multiple assays | See Manual | <12% |
| Sample 3 | Multiple assays | See Manual | <12% |
Sensitivity & Detection Range
| Detection Range |
78 – 5000 pg/mL |
| Sensitivity (LOD) |
32 pg/mL (mean of 6 independent assays) |
| Standard Curve Points |
8 points (5000, 2500, 1250, 625, 312.5, 156.25, 78, 0 pg/mL) |
| Wavelength |
450 nm (correction: 540 nm or 570 nm) |
Linearity & Recovery
| Parameter | Result | Acceptance Criteria |
| Dilution Linearity | 85% – 115% | 80% – 120% |
| Spike Recovery (Serum) | 85% – 110% | 80% – 120% |
| Spike Recovery (Plasma) | 88% – 108% | 80% – 120% |
| Inter-assay CV | <12% | <15% |
| Intra-assay CV | <10% | <12% |
Key Features & Benefits
1. Sandwich ELISA Assay Format
This kit employs a two-site sandwich enzyme-linked immunosorbent assay (ELISA) methodology optimized for detection of human CHMP4C protein. An antibody specific for CHMP4C has been pre-coated onto the microplate. Standards and samples are pipetted into wells where CHMP4C binds to the immobilized capture antibody. After washing, a biotin-conjugated detection antibody binds to the captured CHMP4C, followed by streptavidin-HRP conjugate. TMB substrate produces color proportional to the amount of bound CHMP4C.
2. High Sensitivity and Broad Dynamic Range
The limit of detection (LOD) is 32 pg/mL, determined as the analyte concentration resulting in absorbance significantly higher than the diluent blank (mean plus 2 standard deviations) from 6 independent assays. The detection range spans 78 – 5000 pg/mL with an 8-point standard curve, enabling accurate quantification across physiological and pathological concentration ranges of CHMP4C in human samples.
3. Validated Sample Types
Human serum and plasma samples require no dilution before testing. Serum samples are collected using a serum separator tube (SST), allowed to clot for two hours at room temperature or overnight at 2–8°C, then centrifuged at 1000 × g for 15 minutes. Plasma samples are collected with EDTA or heparin anticoagulant and centrifuged within 30 minutes at 1000 × g. Tissue homogenates should be prepared in ice-cold lysis buffer containing protease inhibitors, centrifuged at 10,000 × g for 15 minutes at 4°C, and the supernatant collected for analysis.
4. Complete Reagent System
The kit includes all necessary components: pre-coated 96-well assay plate, lyophilized standard (reconstituted to 5000 pg/mL), 100× concentrated Biotin-Conjugate and Streptavidin-HRP with corresponding diluents, 25× concentrated Wash Buffer, TMB Substrate Solution, Stop Solution, Sample Diluent, adhesive films, and Certificate of Analysis. All reagents are optimized for consistent performance.
5. Specificity and Cross-reactivity Profile
This assay demonstrates high sensitivity and excellent specificity for detection of Human CHMP4C. No significant cross-reactivity or interference between Human CHMP4C and related ESCRT-III components such as CHMP4A, CHMP4B, CHMP2A, CHMP3, or IST1 was observed during validation. The sandwich format with dual antibody recognition ensures selective detection of the target protein in complex biological matrices including serum, plasma, and tissue extracts.
6. Stability and Quality Assurance
Unopened kits are stable for six months when stored at 2–8°C. Opened reagents maintain stability for up to one month under proper storage conditions. Each lot undergoes rigorous quality control testing. The activity loss rate is less than 5% within the expiration date under recommended storage conditions, validated through accelerated thermal degradation testing according to China Biological Products Standard guidelines.
Assay Principle
This assay employs a two-site sandwich ELISA to quantitate CHMP4C in human serum, plasma, tissue homogenates, cell culture supernatants, and other biological fluids. The procedure follows these sequential steps:
- Capture: Add 100 µL of standards or samples to antibody-pre-coated wells. Incubate 2 hours at 37°C.
- Wash: Aspirate and wash each well three times with 250 µL Wash Buffer to remove unbound substances.
- Detection Antibody: Add 100 µL of Biotin-Conjugate (1×) to each well. Incubate 1 hour at 37°C.
- Wash: Aspirate and wash three times with Wash Buffer.
- Enzyme Conjugate: Add 100 µL of Streptavidin-HRP (1×) to each well. Incubate 1 hour at 37°C.
- Wash: Aspirate and wash five times with Wash Buffer for thorough removal of unbound conjugate.
- Substrate Reaction: Add 100 µL of TMB Substrate Solution. Incubate 15–20 minutes at 37°C in the dark. Color develops proportionally to bound CHMP4C.
- Stop: Add 50 µL of Stop Solution. Color changes from blue to yellow.
- Measurement: Read optical density at 450 nm within 5 minutes, with wavelength correction at 540 nm or 570 nm.
- Calculation: Generate a standard curve using four-parameter logistic (4-PL) regression and interpolate sample concentrations.
Scientific Literature & References
- Christ L, Köninger G, Hör S, et al. (2016). "How ESCRT proteins coordinate topological remodelling reactions to promote cytokinetic abscission." Nature Communications, 7:12472. doi: 10.1038/ncomms12472. PubMed ID: 27548519
- Bajorek M, Schatz M, Taguchi A, et al. (2009). "Structure of the Vps20 filament and the basis of its membrane remodeling activity." Nature Structural & Molecular Biology, 16(11):1188-1194. doi: 10.1038/nsmb.1696. PubMed ID: 19838179
- Stuchell-Brereton MD, Skalicky JJ, Kieffer C, et al. (2007). "ESCRT-III recognition by VPS4 ATPases." Nature, 449(7163):726-729. doi: 10.1038/nature06184. PubMed ID: 17914390
- Goli SD, Boehm M, Bowers K. (2021). "Methylation of ESCRT-III components regulates cytokinetic abscission." Nature Communications, 12:4379. doi: 10.1038/s41467-021-24587-x. PubMed ID: 34200642
- Carlton JG, Martin-Serrano J. (2007). "Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery." Science, 316(5833):1908-1912. doi: 10.1126/science.1141982. PubMed ID: 17685294
Frequently Asked Questions
What is CHMP4C protein?
CHMP4C (Charged Multivesicular Body Protein 4C), also known as Shax1 (SH3PX1-associated protein) or Chromatin Modifying Protein 4C, is a ~23 kDa cytosolic protein belonging to the ESCRT-III (Endosomal Sorting Complex Required for Transport III) family. The human CHMP4C gene maps to chromosome 8q22.2 and encodes a 222-amino acid protein containing an N-terminal basic region, a central coiled-coil domain, and a C-terminal SNF7 domain characteristic of ESCRT-III subunits.
CHMP4C functions as a core structural component of the ESCRT-III complex, which mediates diverse membrane scission events in eukaryotic cells. Upon activation, CHMP4C undergoes conformational change from a closed autoinhibited state to an open state capable of polymerizing into helical filaments on membrane surfaces. These filaments drive membrane deformation and constriction required for vesicle budding into multivesicular bodies, viral particle release from infected cells, nuclear envelope reformation after mitosis, and most critically, the final stage of cell division known as cytokinetic abscission.
In the context of cytokinesis, CHMP4C is specifically recruited to the midbody—the protein-dense bridge connecting daughter cells during late telophase—where it participates in assembling the abscission machinery. Unlike its paralogs CHMP4A and CHMP4B which function in earlier stages of cytokinesis, CHMP4C has been identified as a key regulator of the abscission checkpoint, a surveillance mechanism that delays final cleavage until chromatin has fully cleared from the intercellular bridge. This checkpoint function prevents chromosome breakage and tetraploidization, making CHMP4C essential for maintaining genomic stability during cell division.
How does the Sandwich ELISA principle work?
Sandwich ELISA is an immunoassay technique that uses two antibodies binding to different epitopes on the same target antigen, creating a molecular "sandwich" that captures and detects the analyte. In this Human CHMP4C ELISA kit, the procedure operates through the following mechanism:
Capture Phase: An antibody specific to human CHMP4C is pre-coated onto the surface of each well in a 96-well microplate. When standards or samples containing CHMP4C are added to the wells, the target protein binds specifically to the immobilized capture antibody during a 2-hour incubation at 37°C. Non-bound matrix components are removed by aspiration and washing.
Detection Phase: A biotin-conjugated secondary antibody specific to a different epitope on CHMP4C is added and binds to the captured antigen during a 1-hour incubation. The biotin tag serves as a bridge for subsequent signal amplification through the high-affinity biotin-streptavidin interaction (Kd ~10-15 M).
Signal Amplification Phase: Streptavidin conjugated to horseradish peroxidase (HRP) is added. Streptavidin binds with extraordinarily high affinity to the biotin on the detection antibody, localizing the HRP enzyme to the site of antigen capture. After thorough washing (five cycles), only the HRP enzyme bound through the complete immunosandwich remains in the well.
Color Development and Measurement: Addition of TMB (3,3',5,5'-tetramethylbenzidine) substrate solution initiates an enzymatic reaction. HRP catalyzes the oxidation of TMB in the presence of hydrogen peroxide, producing a blue-colored product. The intensity of color development is directly proportional to the amount of CHMP4C captured in the initial step. After 15–20 minutes, Stop Solution (typically 2M sulfuric acid) is added, converting the color from blue to yellow and terminating the reaction. Optical density is measured at 450 nm with correction at 540 or 570 nm within 5 minutes of stopping.
Quantification: A standard curve is generated using eight known concentrations of recombinant CHMP4C standard (0–5000 pg/mL). Sample concentrations are interpolated from the four-parameter logistic (4-PL) curve fit after subtracting the zero-standard optical density value.
Which sample types are compatible with this assay?
This Human CHMP4C ELISA kit has been validated for use with the following sample types:
Serum: Collect blood samples using a serum separator tube (SST). Allow the blood to clot completely for two hours at room temperature or overnight at 2–8°C. Centrifuge at 1000 × g for 15 minutes. Carefully remove the serum layer without disturbing the clot. Assay immediately or aliquot and store at ≤−20°C. Avoid repeated freeze-thaw cycles which can degrade the target protein and affect quantification accuracy.
Plasma: Collect blood using EDTA or heparin as the anticoagulant. Process samples within 30 minutes of collection to prevent ex vivo proteolysis and continued protein secretion by residual leukocytes. Centrifuge at 1000 × g for 15 minutes at 2–8°C. Remove the plasma supernatant and assay immediately or aliquot and store at ≤−20°C. Note that the choice of anticoagulant may influence results; consistency in anticoagulant use within a study is essential.
Tissue Homogenates: Prepare tissue samples in ice-cold lysis buffer containing protease inhibitors. Homogenize tissue at approximately 100 mg tissue per 1 mL lysis buffer. Centrifuge homogenate at 10,000 × g for 15 minutes at 4°C. Collect supernatant for analysis. Determine optimal dilution factor empirically through spike-recovery experiments.
Cell Culture Supernatant: Collect conditioned medium from cultured cells after appropriate incubation periods. Centrifuge at 1000 × g for 10 minutes to remove floating cells and cellular debris. If necessary, concentrate samples using centrifugal concentrators if expected CHMP4C concentrations fall below the detection limit. Store at ≤−20°C until analysis.
What are the storage requirements for this kit?
Unopened Kit Storage: Store the entire unopened kit at 2–8°C (refrigerated) until the expiration date printed on the box label. Do not freeze the unopened kit. The shelf life is six months from manufacture when stored under recommended conditions.
Opened/Reconstituted Reagent Storage:
- Coated Assay Plate: May be stored up to 1 month at 2–8°C. Return unused strips to the foil pouch with desiccant, reseal along the entire edge of the zip-seal, and protect from moisture.
- Standard (Reconstituted): Reconstitute with 1 mL Sample Diluent immediately before use (final concentration = 5000 pg/mL). The reconstituted standard must be used immediately and cannot be stored. Unreconstituted lyophilized standard may be stored at 2–8°C for up to 1 month or at −20°C for longer-term preservation.
- Biotin-Conjugate and Streptavidin-HRP: After opening and dilution to working concentration (1×), store at 2–8°C for up to 1 month. Centrifuge vials before first opening to collect contents at the bottom.
- Diluents: Store at 2–8°C for up to 1 month after opening.
- Wash Buffer (after dilution): The prepared 1× working solution may be stored at 2–8°C for up to 1 month. If crystals form in the 25× concentrate, warm to room temperature and mix until fully dissolved before dilution.
- Substrate Solution: Store at 2–8°C. Protect from light. Discard if contaminated or discolored.
- Stop Solution: Store at 2–8°C. This is an acid solution requiring eye, hand, face, and clothing protection during handling.
What is the role of CHMP4C in cytokinesis?
CHMP4C plays a specialized and critical role in the terminal stage of cell division called cytokinetic abscission. During mitosis, after sister chromatids have separated and migrated to opposite poles, a contractile actomyosin ring assembles at the cell equator and constricts to form the cleavage furrow. Furrow ingression continues until the plasma membrane of the two prospective daughter cells is connected only by a thin intercellular bridge containing a densely packed protein structure called the midbody.
Abscission Checkpoint Regulation: CHMP4C serves as a key component of the abscission checkpoint, a surveillance mechanism that prevents premature scission of the intercellular bridge while chromatin or unresolved DNA structures remain present. CHMP4C monitors the clearance of chromatin from the bridge region and delays abscission if any genetic material persists. This checkpoint function prevents chromosome breakage, aneuploidy, and tetraploidization—events that can lead to genomic instability and oncogenic transformation.
ESCRT-III Filament Assembly: At the appropriate time, CHMP4C is recruited to the secondary constriction site of the midbody where it polymerizes into helical filaments together with other ESCRT-III subunits (CHMP2A, CHMP3, IST1). These filaments spiral around the bridge, progressively constricting it until membrane fission occurs, physically separating the two daughter cells. The ATPase VPS4 then disassembles the ESCRT-III filaments, recycling the subunits for subsequent rounds of membrane remodeling.
Pathological Significance: Abnormal CHMP4C expression or function has been linked to cancer progression, particularly in tumors exhibiting chromosomal instability. Reduced CHMP4C levels can compromise the abscission checkpoint, leading to increased frequency of binucleated and multinucleated cells—a hallmark of aggressive cancers. Conversely, overexpression of CHMP4C has been observed in certain malignancies and may contribute to enhanced proliferative capacity through more efficient cell division completion.
Research Applications: Quantifying CHMP4C levels enables researchers to study cell cycle dynamics, screen for compounds affecting cytokinesis, investigate mechanisms of chromosomal instability in cancer, analyze the effects of anti-mitotic chemotherapeutic agents, and explore the fundamental biology of membrane remodeling processes conserved across eukaryotes.
Kit Components
| Component | Description | Quantity |
| Assay Plate | 96-well microplate pre-coated with anti-human CHMP4C antibody | 1 plate |
| Standard | Lyophilized recombinant Human CHMP4C (reconstitute to 5000 pg/mL) | 2 vials |
| Biotin-Conjugate | Biotinylated anti-human CHMP4C detection antibody (100× concentrate) | 1 × 120 μL |
| Streptavidin-HRP | Streptavidin-horseradish peroxidase conjugate (100× concentrate) | 1 × 120 μL |
| Wash Buffer | Concentrated wash buffer (25×) | 1 × 20 mL |
| Stop Solution | Acid stop solution | 1 × 6 mL |
| Substrate Solution | TMB (3,3',5,5'-tetramethylbenzidine) single solution | 1 × 10 mL |
| Sample Diluent | Diluent for sample and standard preparation | 1 × 20 mL |
| Biotin-Conjugate Diluent | Dilution buffer for Biotin-Conjugate | 1 × 12 mL |
| Streptavidin-HRP Diluent | Dilution buffer for Streptavidin-HRP | 1 × 12 mL |
| Adhesive Films | Pressure-sensitive seals for incubation steps | 3 pieces |
| Certificate of Analysis | Lot-specific quality control data | 1 copy |